Evidence map›Paper›PMID 37148431›Full record

ArticleMetabolic brain disease2023

Neurometabolic changes in a rat pup model of type C hepatic encephalopathy depend on age at liver disease onset.

Dunja Simicic, Veronika Rackayova, Olivier Braissant, Christian Toso, Graziano Oldani, Dario Sessa, Valérie A McLin, Cristina Cudalbu

Open access · hybridAbstract read
In one paragraph

Article in Metabolic brain disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Combining sorafenib andIranian journal of basic medical sciences · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Dunja Simicic *CIBM Center for Biomedical Imaging, Lausanne, Switzerland. dunja.simicic@epfl.ch.ORCID http://orcid.org/0000-0002-6600-2696
Veronika Rackayova *CIBM Center for Biomedical Imaging, Lausanne, Switzerland.
Olivier BraissantService of Clinical Chemistry, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Christian TosoDivision of Abdominal and Transplantation Surgery, Department of Surgery, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.
Graziano OldaniDivision of Abdominal and Transplantation Surgery, Department of Surgery, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.
Dario SessaSwiss Pediatric Liver Center, Department of Pediatrics, Gynecology and Obstetrics, University of Geneva, Geneva, Switzerland.
Valérie A McLin *Swiss Pediatric Liver Center, Department of Pediatrics, Gynecology and Obstetrics, University of Geneva, Geneva, Switzerland.
Cristina Cudalbu *CIBM Center for Biomedical Imaging, Lausanne, Switzerland. cristina.cudalbu@epfl.ch.
Centre d'Imagerie BioMedicale · CHUniversity Hospital of Geneva · CHUniversity of Geneva · CHUniversity of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic liver disease (CLD) is a serious condition where various toxins present in the blood affect the brain leading to type C hepatic encephalopathy (HE). Both adults and children are impacted, while children may display unique vulnerabilities depending on the affected window of brain development.We aimed to use the advantages of high field proton Magnetic Resonance Spectroscopy (

Indexed as

Hepatic EncephalopathyLiver DiseasesAdultAnimalsBrainChildGlutamineHumansLactic AcidMagnetic Resonance SpectroscopyRatsGlutamineLactic Acid1H MRSBile duct ligationChronic liver diseaseNeurodevelopmentType C hepatic encephalopathy

Identifiers

PMID37148431
PMCPMC10348928
OpenAlexW4375856033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.